Publications
Found 3 results
Filters: Author is Cameron, Michael D [Clear All Filters]
(2022)
A novel HER2-selective kinase inhibitor is effective in HER2 mutant and amplified non-small cell lung cancer. Cancer Res. 10.1158/0008-5472.CAN-21-2693
(2022) (2019)